Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Temperature Cycling Testing for Aerosols

Posted on By

SOP for Temperature Cycling Testing for Aerosols

Standard Operating Procedure for Temperature Cycling Testing for Aerosols

1) Purpose

The purpose of this SOP is to establish procedures for conducting temperature cycling testing on aerosol products to evaluate product stability and performance under varied temperature conditions.

2) Scope

This SOP applies to temperature cycling testing performed on aerosol products manufactured by [Company Name] to assess product integrity and reliability throughout storage and distribution.

3) Responsibilities

Quality Control (QC) Team: Perform temperature cycling testing according to approved protocols and acceptance criteria.
Production Team: Provide aerosol products for testing and coordinate sample collection.
Engineering Team: Maintain temperature cycling chambers and equipment to ensure accurate and repeatable testing conditions.
Regulatory Affairs: Review and approve testing protocols to ensure compliance with regulatory requirements.

4) Procedure

4.1 Equipment Setup and Calibration:
4.1.1 Ensure temperature cycling chambers and monitoring equipment are calibrated and maintained according to manufacturer specifications.
4.1.2 Verify equipment functionality and performance prior to testing by conducting temperature mapping and validation studies.
4.1.3 Record calibration and validation activities in the equipment logbook.

See also  SOP for Process Validation Protocols for Aerosols

4.2 Sample Selection and Preparation:
4.2.1 Select representative samples of aerosol products from production batches or stability studies for temperature cycling testing.
4.2.2 Ensure samples are labeled and identified to maintain traceability throughout testing.
4.2.3 Equilibrate samples to specified storage conditions (e.g., room temperature) before initiating temperature cycling.

4.3 Temperature Cycling Conditions:
4.3.1 Define temperature cycling parameters including upper and lower temperature limits, ramp rates, and duration of each cycle.
4.3.2 Program temperature cycling chambers to alternate between defined temperature extremes at specified intervals (e.g., daily, weekly).
4.3.3 Monitor and record temperature fluctuations within the chambers to ensure adherence to programmed conditions.

See also  SOP for Production Scheduling for Aerosols

4.4 Testing Duration:
4.4.1 Conduct temperature cycling testing for a predetermined duration based on product-specific requirements and regulatory guidelines.
4.4.2 Perform periodic evaluations of samples during testing intervals to assess changes in product appearance, physical integrity, and performance.
4.4.3 Document observations and measurements of sample responses to temperature cycling conditions.

4.5 Evaluation and Acceptance Criteria:
4.5.1 Evaluate test results against predefined acceptance criteria for product stability and performance parameters.
4.5.2 Assess changes in aerosol product attributes including but not limited to leakage, formulation integrity, propellant stability, and container integrity.
4.5.3 Document all test results, including pass/fail determinations and deviations encountered during testing.

4.6 Reporting and Documentation:
4.6.1 Prepare comprehensive test reports summarizing temperature cycling methods, results, and interpretations.
4.6.2 Review and approve test reports by designated personnel to ensure accuracy and compliance with SOPs.
4.6.3 Maintain records of all temperature cycling testing activities, including raw data, test protocols, and approval documentation.

See also  SOP for Batch Record Review in Aerosol Production

4.7 Non-Conformance Handling:
4.7.1 Initiate non-conformance reports (NCRs) for aerosol products that fail temperature cycling testing, documenting reasons for failure and corrective actions taken.
4.7.2 Implement corrective actions to address identified issues, such as adjusting product formulation or packaging materials.
4.7.3 Verify effectiveness of corrective actions through retesting and document outcomes accordingly.

5) Abbreviations, if any

SOP: Standard Operating Procedure
QC: Quality Control
NCR: Non-Conformance Report

6) Documents, if any

Temperature Cycling Testing Protocol
Temperature Cycling Test Reports
Equipment Calibration Records
Non-Conformance Reports (NCRs)
Approval Records and Documentation

7) Reference, if any

ICH Q1A(R2): Stability Testing of New Drug Substances and Products
ISO 11607-1: Packaging for Terminally Sterilized Medical Devices – Part 1: Requirements for Materials, Sterile Barrier Systems, and Packaging Systems
USP Chapter Aerosols – Determination of Leak Rate

8) SOP Version

Version 1.0

Aerosols Tags:Aerosol batch manufacturing, Aerosol change control procedures, Aerosol cleaning validation, Aerosol contamination prevention, Aerosol documentation requirements, Aerosol equipment calibration, Aerosol equipment cleaning, Aerosol final product inspection, Aerosol formulation development, Aerosol in-process testing, Aerosol manufacturing process, Aerosol method development, Aerosol microbial testing, Aerosol packaging guidelines, Aerosol particle size analysis, Aerosol personnel training, Aerosol process validation, Aerosol production SOP, Aerosol quality control, Aerosol raw material inspection, Aerosol stability testing, Aerosol stability testing methods, Aerosol sterility maintenance, Aerosol storage conditions, Aerosol waste disposal procedures

Post navigation

Previous Post: SOP for Pharmacovigilance Adverse Event (AE) Reporting
Next Post: SOP for Packaging Integrity Testing

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version